LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $212 | -99.9% | 2,945 | -23.0% | 0.02% | -74.6% |
| Q3 2020 | $365,000 | -2.1% | 3,827 | +14.6% | 0.06% | +46.5% |
| Q2 2020 | $373,000 | +30.4% | 3,339 | +21.6% | 0.04% | +53.6% |
| Q4 2019 | $286,000 | +28.8% | 2,747 | +22.9% | 0.03% | +64.7% |
| Q3 2019 | $222,000 | -48.5% | 2,235 | -34.8% | 0.02% | -29.2% |
| Q1 2019 | $431,000 | +103.3% | 3,429 | +119.1% | 0.02% | +118.2% |
| Q4 2018 | $212,000 | -37.3% | 1,565 | +27.1% | 0.01% | -47.6% |
| Q3 2018 | $338,000 | +11.2% | 1,231 | -44.6% | 0.02% | +31.2% |
| Q4 2017 | $304,000 | -62.2% | 2,222 | -62.4% | 0.02% | -60.0% |
| Q3 2017 | $805,000 | – | 5,916 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |